Pentoxifylline prevention of altered hepatocyte calcium regulation during hemorrhagic shock/resuscitation

Critical Care Medicine

Volumn 26, Issue 3, 1998, Pages 494-500

  Silomon, Malte ^a   Pizanis, Antonius ^a   Larsen, Reinhard ^a   Rose, Stefan ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Calcium; Hemorrhage; Hepatocyte; Ischem ia reperfusion; Lipid peroxidation; Liver; Oxygen free radicals; Pentoxifylline; Resuscitation; Shock

Indexed keywords

CALCIUM ION; PENTOXIFYLLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM MOBILIZATION; CELL PROTECTION; CONTROLLED STUDY; HEMORRHAGIC SHOCK; INTRAVENOUS DRUG ADMINISTRATION; LIVER INJURY; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; RESUSCITATION; TRANSPORT KINETICS;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCIUM; EPINEPHRINE; GLUTATHIONE; HEMODYNAMIC PROCESSES; LIPID PEROXIDATION; LIVER; MALE; OXIDATION-REDUCTION; PENTOXIFYLLINE; RATS; RATS, SPRAGUE-DAWLEY; RESUSCITATION; SHOCK, HEMORRHAGIC; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0031936114     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199803000-00021     Document Type: Article

References (42)

1. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee: American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20: 864-874
2. Donelly SC, Robertson C: Mediators, mechanisms and mortality in major trauma. Resuscitation 1994; 28:87-92
3. Roumen RMH, Redl H, Schlag G, et al: Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma. Crit Care Med 1995; 23: 474-480
4. Bauer C, Roth W, Bahrami S, et al: Attenuation of shock-induced inflammation in the rat liver depends on the time of TNFα-inhibition. J Mol Med 1996; 74:51-58
5. Rasmussen H, Barrett PQ: Calcium messenger system: An integrated view. Physiol Rev 1984; 64:938-984
6. 2+-related hepatocellular alterations during intra-abdominal sepsis. Am J Physiol 1992; 263:R553-R558
7. 2+: A critical link in the pathophysiology of sepsis? Proc Natl Acad Sci USA 1993; 90: 3933-3937
8. Sayeed MM: Alterations in calcium signaling and cellular responses in septic injury. New Horiz 1996; 4:72-86
9. Orrenius S, McConkey DJ, Nicotera P: Role of calcium in toxic and programmed cell death. Adv Exp Med Biol 1991; 283:419-425
10. Maitra SR, Geller ER, Pan W, et al: Altered cellular calcium regulation and hepatic glucose production during hemorrhagic shock. Circ Shock 1992; 38: 14-21
11. 2+ regulation during hemorrhagic shock and resuscitation. Hepatology 1997; 25:379-384
12. Müller R: Pentoxifylline - A biomedical profile. J Med 1979; 10:307-329
13. Sullivan GW, Carper HT, Novick WJ, et al: Inhibition of the inflammatory action of interleukin-1 and tumor necrosis factor (alpha) on neutrophil function by pentoxifylline. Infect Immun 1988; 56:1722-1729
14. Crouch SPM, Fletcher J: Effect of ingested Pentoxifylline on neutrophil superoxide anion production. Infect Immun 1992; 60:4504-4509
15. Strieter RM, Remick DG, Ward PA, et al: Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. Biochem Biophys Res Commun 1988; 155:1230-1236
16. Schandené L, Vandenbussche P, Crusiaux A, et al: Differential effects of pentoxifylline on the production of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) by monocytes and T cells. Immunology 1992; 76:30-34
17. Kato H, Ishitoya J, Takenawa T: Inhibition of inositol phospholipids metabolism and calcium mobilization by cyclic AMP-increasing agents and phorbol ester in neutrophils. Biochem Biophys Res Commun 1986; 139: 1272-1278
18. Combettes L, Berthon B, Claret M: Caffeine inhibits cytosolic calcium oscillations induced by noradrenaline and vasopressin in rat hepatocytes. Biochem J 1994; 301:737-744
19. Marzi I, Maier M, Herzog C, et al: Influence of pentoxifylline and albifylline on liver microcirculation and leukocyte adhesion after hemorrhagic shock in the rat. J Trauma 1996; 40:90-96
20. Barritt GJ, Parker JC, Wadsworth JC: A kinetic analysis of the effects of adrenaline on calcium distribution in isolated rat liver parenchymal cells. J Physiol 1981; 312:29-55
21. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95:351-358
22. Hissin PJ, Hilf R: A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74:214-226
23. Lowry OH, Rosebrough NJ, Farr AL, et al: Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193:265-275
24. Zapata-Sirvent RL, Hansbrough JF, Cox MC, et al: Immunologic alterations in a murine model of hemorrhagic shock. Crit Care Med 1992; 20:508-517
25. Haglund U, Gerdin B: Oxygen-free radicals (OFR) and circulatory shock. Circ Shock 1991; 34:405-411
26. Bauer M, Feucht K, Ziegenfuss T, et al: Attenuation of shock-induced hepatic microcirculatory disturbances by the use of a starch-deferoxamine conjugate for resuscitation. Crit Care Med 1995; 23:316-322
27. Flynn WJ, Cryer HG, Garrison RN: Pentoxifylline but not saralasin restores hepatic blood flow after resuscitation from hemorrhagic shock. J Surg Res 1991; 50:616-621
28. Flynn WJ, Cryer HG, Garrison RN: Pentoxifylline restores intestinal microvascular blood flow during resuscitated hemorrhagic shock. Surgery 1991; 110:350-356
29. Coccia MT, Waxman K, Soliman MH, et al: Pentoxifylline improves survival following hemorrhagic shock. Crit Care Med 1989; 17:36-38
30. Wang P, Ba ZF, Morrison MH, et al: Mechanism of the beneficial effects of pentoxifylline on hepatocellular function after trauma hemorrhage and resuscitation. Surgery 1992; 112:451-458
31. Waxman K, Clark L, Soliman MH, et al: Pentoxifylline in resuscitation of experimental hemorrhagic shock. Crit Care Med 1991; 19:728-731
32. Rall TW: Drugs in the treatment of asthma. The methylxanthines, cromolyn sodium and other agents. In: The Pharmacological Basis of Therapeutics. Goodman LS, Gilman A (Eds). New York, Pergamon Press, 1990, pp 618-637
33. Cederna J, Bandlien K, Toledo-Pereyra LH, et al: Effect of allopurinol and/or catalase on hemorrhagic shock and their potential application to multiple organ harvesting. Transplant Proc 1990; 22:444-445
34. Nakamura S, Asaoka Y, Yoshida U: Protein kinase C for cell signaling: a possible link between phospholipasis. In: Advances In Second Messenger and Phosphoprotein Research. Braun BL, Dobson PR (Eds). New York, Raven Press, 1993, pp 171-178
35. 2+ in hepatocytes following alpha-adrenergic stimulation. J Biol Chem 1983; 258:8769-8773
36. Rose S, Sayeed MM: Superoxide radical scavenging prevents cellular calcium dysregulation during intraabdominal sepsis. Shock 1997; 7:263-268
37. Rose S, Floyd RA, Eneff K, et al: Intestinal ischemia: Reperfusion mediated increase in hydroxyl free radical formation as reported by salicylate hydroxylation. Shock 1994; 1:452-456
38. Landon EJ, Jaiswal RK, Naukam RJ, et al: Effects of calcium channel blocking agents on membrane microviscosity and calcium in the liver of the carbon tetrachloride treated rat. Biochem Pharmacol 1984; 33:3553-3560
39. Van der Vliet A, Bast A: Effect of oxidative stress on receptors and signal transmission. Chem Biol Interactions 1992; 85:95-116
40. Albano E, Bellomo G, Parola M, et al: Stimulation of lipid peroxidation increases the intracellular calcium content of isolated hepatocytes. Biochim Biophys Acta 1991; 1091:310-316
41. 2+ Influx. Cell Signal 1994; 6:493-501
42. 2+ accumulation and transglutaminase activation in rat erythrocytes. J Clin Pharmacol 1991; 31:531-536